2024年３月期 第３四半期決算短信〔日本基準〕（連結）

This document provides information on the consolidated financial results for the third quarter of the fiscal year ending March 2024 for Kawachi Drugs Co., Ltd. As of December 15, 2023, the cumulative sales amounted to 215,830 million yen, with operating profit at 6,073 million yen, ordinary profit at 6,880 million yen, and net profit attributable to shareholders at 4,306 million yen. The economic environment is showing signs of recovery from the impact of COVID-19, but challenges such as rising resource prices and intensified competition remain. Kawachi Drugs is focusing on new store openings and pharmacy installations to enhance sales efforts.